Live Breaking News & Updates on வாலண்டைன் புஸ்தேர்

Stay updated with breaking news from வாலண்டைன் புஸ்தேர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Diabetes Aside, HbA1c a Telling Indicator of Arterial Buildup


email article
Glycated hemoglobin (HbA1c) could have prognostic value for people without diabetes and no history of cardiovascular disease (CVD), according to an observational study of nearly 4,000 middle-age individuals.
In the PESA study, HbA1c showed a graded, positive association with the prevalence and multi-territorial extent of subclinical atherosclerosis detected by vascular ultrasound and noncontrast cardiac CT, reported Valentin Fuster, MD, PhD, of the Icahn School of Medicine at Mount Sinai in New York City and Centro Nacional de Investigaciones Cardiovasculares Carlos III in Madrid, and colleagues.
This association was independent of traditional cardiovascular risk factors and was significant in all prediabetes groups, even below the prediabetes cutoff (HbA1c 5.5%-5.6%; OR 1.36, 95% CI 1.03-1.80, ....

New York , United States , Coll Cardiol , Nicole Lou , Raul Santos , Investigaciones Cardiovasculares Carlos , Valentin Fuster , Paulo Medical School , Santander Bank Headquarters , Icahn School Of Medicine At Mount Sinai , Journal Of The American College Cardiology , Heart Institute , Icahn School , Mount Sinai , New York City , American College , Systematic Coronary Risk Estimation , Medpage Today , Cardiovascular Disease , Type 2 Diabetes , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , நிக்கோல் லூ , ரால் சாண்டோஸ் , வாலண்டைன் புஸ்தேர் , பாலொ மருத்துவ பள்ளி ,

Mount Sinai Cardiologist Roxana Mehran, MD, Leads First-Ever Commission to Help Reduce Global Burden of Women's Heart Disease


May 17, 2021
Group’s worldwide health recommendations aim to improve outcomes by 2030
(New York, NY – May 16, 2021) – A unique commission that today issued major new recommendations aimed at fully understanding and reducing the global burden of heart disease in women was led by Roxana Mehran, MD,
 Professor of Medicine, and Population Health Science and Policy, and Director of Interventional Cardiovascular Research and Clinical Trials at the Icahn School of Medicine at Mount Sinai.
“The Lancet Women and Cardiovascular Disease Commission” developed specific, worldwide recommendations for heart disease prevention and treatment based on an unprecedented global review and analysis. The recommendations included expanding education and health programs, and research on women’s heart disease. The commission’s report was published on May 16 in  ....

New York , United States , Long Island , Roxana Mehran , Valentin Fuster , Interventional Cardiovascular Research , Institute For Health Metrics , University Of Washington , Population Health Science , Bristol Myers Squibb , Health System , Cardiovascular Disease Commission , American College Of Cardiology , Icahn School Of Medicine At Mount Sinai , Mount Sinai Health System , Icahn School Of Medicine , Clinical Trials , Icahn School , Lancet Women , Cardiovascular Disease , American College , Annual Scientific , Disease Study , Health Metrics , Mount Sinai , Mount Sinai Heart ,